Skip to content
buyWeak

Heidi Hunter bought $21k of IOBT

director at IO Biotech, Inc.. 15,000 shares at an average of $1.39, traded May 30, 2025, filed Jun 2, 2025.

Conviction score
23
Value
$21k
15,000 shares
Holdings after
15,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $21k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000905148-25-001960, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 30, 2025POpen-market purchase
Common Stock
+15,000$1.39$21k15,000Jun 2, 2025

Related signals

Other insiders at IO Biotech, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
IOBTbuy 4
IO Biotech, Inc.
Qasim Iftikhar Ahmad
Chief Medical Officer
$27k
31,350 shares
-
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Devin Whittemore Smith
General Counsel
$9,720
12,000 shares
+243%
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Amy Sullivan
Chief Financial Officer
$8,483
10,250 shares
+14%
46Moderate
IOBTbuy 4
IO Biotech, Inc.
Mai-Britt Zocca
Chief Executive Officer
$10k
12,500 shares
+33%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Heidi Hunter bought $21k of IOBT | InsiderTell